Table 1

Baseline and treatment cycle parameters with ovulation dysfunction criteria

Cycle 1: Baseline cycleCycle 2: Treatment cycle
SubjectTotal cycle length
(days)
LF >18 mmTotal cycle length
(days)
LF >18 mm,
day of medication
LF maximum diameter
(mm)
Maximum ES thickness
(mm)
*Luteal P level
(ng/mL)
Ovulation dysfunction
Ovulation disruptionLH surge blunted*Non-ovulatory luteal PMet >1 ovulation dysfunction criteria
Cycle dayLH level
(IU/L)
Cycle DayLH level
(IU/L)
LF persist
>5 days
0127108.731107.224.221.61.3YesYesYesYes
0232124.4321318.522.911.55.7NoYesNoYes
04291113.629106.225.79.306.6YesNoNoYes
05341734.8371614.621.012.11.5YesNoYesYes
06261013.928107.823.112.85.3NoNoNoNo
072595.434115.721.812.74YesYesNoYes
092499.727117.923.99.68.8YesYesNoYes
1032149.8361710.918.912.33YesNoNoYes
12281055.231106.8017.411.65.4NoYesNoYes
Mean28.61117.331.9129.522.112.64.6
SD3.52.716.84.02.74.42.63.62.4
Median28.010.09.832.011.07.822.912.15.3
Range24–349–174.4–55.227–3710–175.7–18.517.4–25.79.3–21.61.3–8.8
  • Ovulation dysfunction criteria defined based on established definitions from prior studies.

  • *Ovulatory luteal phase progesterone level defined as >3.5

  • ES, endometrial stripe; LF, lead follicle; LH, luteinizing hormone; P, progesterone; SD, standard deviation.